Encyclopedia

  • Physicochemical evaluation and non-isothermal kinetic study of the drug–excipient interaction between DOXEPIN (cas 1668-19-5) and lactose
  • Add time:09/27/2019         Source:sciencedirect.com

    In this study, the incompatibility of DOXEPIN (cas 1668-19-5) in solid physical mixtures with lactose (monohydrate and anhydrous) was investigated. The compatibility testing was made using various physicochemical techniques, such as differential scanning calorimetry (DSC), Fourier-transform infrared (FTIR) spectroscopy, and mass spectrometry. Non-isothermally stressed physical mixtures were used to analyze the solid-state kinetic parameters. Data were fitted to different thermal models, such as Friedman, Flynn–Wall–Ozawa (FWO) and Kissinger–Akahira–Sunose (KAS) for different drug–excipient mixtures separately. Overall, the incompatibility of doxepin as a tertiary amine, with lactose as a reducing carbohydrate was successfully evaluated. DSC based kinetic analysis provided a simple and fast comparative data in different drug–excipient mixtures. It can be recommended to exclude lactose from doxepin's solid dosage formulations, and also to use the described procedure in the kinetic evaluation of drug–excipient incompatibility studies.

    We also recommend Trading Suppliers and Manufacturers of DOXEPIN (cas 1668-19-5). Pls Click Website Link as below: cas 1668-19-5 suppliers


    Prev:Clinical reviewDOXEPIN (cas 1668-19-5) for insomnia: A systematic review of randomized placebo-controlled trials
    Next: Research paperAntidepressant polypharmacy and the potential of pharmacokinetic interactions: DOXEPIN (cas 1668-19-5) but not mirtazapine causes clinically relevant changes in venlafaxine metabolism)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View